←Back to structures
rifoxyc1_full_scaffold_3_prodigal-single.1__X__X__00278
Bact-Virrifoxyc1_full_scaffold_3_prodigal-single.1__X__X__00278
3D Structure
Domains
high = three domain segmentations agree, medium = two domain segmentations agree. Numbered high-first then medium, N→C within each tier.
D1
high
residues 17-118
Domain cluster:
representative
CATH (22)
| Domain ID | Class ID | Classification | TM-score | Bits | E-value | Q cov | T cov |
|---|---|---|---|---|---|---|---|
| 3hi2B00 | 3.30.2310.40 | Alpha Beta › 2-Layer Sandwich › YaeB-like fold › | 0.71 | 58.0 | 6.01e-01 | 89.2% | 91.8% |
| 1wmiA00 | 3.30.2310.20 | Alpha Beta › 2-Layer Sandwich › YaeB-like fold › RelE-like | 0.67 | 53.0 | 5.71e-01 | 92.2% | 97.7% |
| 4exrA02 | 3.10.450.40 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.66 | 37.0 | 4.34e-01 | 89.2% | 78.9% |
| 5cw7B00 | 3.30.2310.20 | Alpha Beta › 2-Layer Sandwich › YaeB-like fold › RelE-like | 0.62 | 50.0 | 5.23e-01 | 90.2% | 92.6% |
| 4ml0B00 | 3.30.2310.20 | Alpha Beta › 2-Layer Sandwich › YaeB-like fold › RelE-like | 0.62 | 51.0 | 5.36e-01 | 92.2% | 98.9% |
| 4exrA01 | 3.10.450.40 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.60 | 37.0 | 4.04e-01 | 92.2% | 75.3% |
| 4n6tA00 | 3.10.450.10 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.60 | 41.0 | 4.62e-01 | 89.2% | 91.1% |
| 1jssA00 | 3.30.530.20 | Alpha Beta › 2-Layer Sandwich › Alpha-D-Glucose-1,6-Bisphosphate; Chain A, domain 4 › START domain | 0.58 | 41.0 | 3.33e-01 | 73.5% | 91.0% |
| 1iz6A01 | 2.30.30.30 | Mainly Beta › Roll › SH3 type barrels. › | 0.57 | 35.0 | 4.13e-01 | 83.3% | 89.9% |
| 3fkaB00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.56 | 47.0 | 4.45e-01 | 91.2% | 89.2% |
| 2a0aA00 | 2.40.128.20 | Mainly Beta › Beta Barrel › Lipocalin › Calycin beta-barrel core domain | 0.55 | 46.0 | 4.25e-01 | 91.2% | 89.3% |
| 7r97A02 | 3.30.160.20 | Alpha Beta › 2-Layer Sandwich › Double Stranded RNA Binding Domain › | 0.54 | 34.0 | 4.01e-01 | 84.3% | 94.1% |
| 3f40A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.53 | 44.0 | 4.30e-01 | 90.2% | 84.7% |
| 4r80A00 | 3.10.450.630 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.53 | 35.0 | 4.02e-01 | 91.2% | 90.8% |
| 4orlA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.53 | 43.0 | 4.27e-01 | 92.2% | 93.6% |
| 1whqA01 | 3.30.160.20 | Alpha Beta › 2-Layer Sandwich › Double Stranded RNA Binding Domain › | 0.52 | 34.0 | 3.85e-01 | 84.3% | 93.0% |
| 4h61A00 | 3.10.450.580 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › Mediator complex, subunit Med6 | 0.52 | 36.0 | 3.27e-01 | 70.6% | 94.2% |
| 1dbzA01 | 3.30.540.10 | Alpha Beta › 2-Layer Sandwich › Fructose-1,6-Bisphosphatase; Chain A, domain 1 › Fructose-1,6-Bisphosphatase, subunit A, domain 1 | 0.52 | 41.0 | 3.42e-01 | 85.3% | 70.1% |
| 2e3nA00 | 3.30.530.20 | Alpha Beta › 2-Layer Sandwich › Alpha-D-Glucose-1,6-Bisphosphate; Chain A, domain 4 › START domain | 0.51 | 40.0 | 3.10e-01 | 83.3% | 74.0% |
| 3v8uA03 | 2.40.128.240 | Mainly Beta › Beta Barrel › Lipocalin › | 0.51 | 34.0 | 3.65e-01 | 88.2% | 78.9% |
| 7wffb01 | 2.70.98.10 | Mainly Beta › Distorted Sandwich › Beta-galactosidase; Chain A, domain 5 › | 0.50 | 41.0 | 2.97e-01 | 89.2% | 74.5% |
| 3fgqA01 | 2.30.39.10 | Mainly Beta › Roll › Alpha-1-antitrypsin; domain 1 › Alpha-1-antitrypsin, domain 1 | 0.50 | 41.0 | 3.35e-01 | 87.3% | 81.9% |
ECOD (43)
| UID | F-ID | Classification | TM-score | Bits | E-value | Q cov | T cov |
|---|---|---|---|---|---|---|---|
| 4959385 | 4312.1.1.0 ↗ | a+b two layers › RelE-like › RelE-like › RelE-like | 0.80 | 57.0 | 6.57e-01 | 90.2% | 100.0% |
| 5081030 | 4312.1.1.0 ↗ | a+b two layers › RelE-like › RelE-like › RelE-like | 0.77 | 55.0 | 6.27e-01 | 89.2% | 100.0% |
| 4994079 | 4312.1.1.0 ↗ | a+b two layers › RelE-like › RelE-like › RelE-like | 0.76 | 54.0 | 6.22e-01 | 89.2% | 100.0% |
| 4992633 | 4312.1.1.15 ↗ | a+b two layers › RelE-like › RelE-like › RelE-like › DUF4258 | 0.75 | 53.0 | 6.07e-01 | 92.2% | 100.0% |
| 5062732 | 4312.1.1.0 ↗ | a+b two layers › RelE-like › RelE-like › RelE-like | 0.75 | 53.0 | 5.80e-01 | 91.2% | 88.2% |
| 4968138 | 4312.1.1.15 ↗ | a+b two layers › RelE-like › RelE-like › RelE-like › DUF4258 | 0.74 | 56.0 | 5.98e-01 | 91.2% | 90.0% |
| 4968653 | 4312.1.1.15 ↗ | a+b two layers › RelE-like › RelE-like › RelE-like › DUF4258 | 0.72 | 59.0 | 6.18e-01 | 94.1% | 92.6% |
| 4966488 | 4312.1.1.0 ↗ | a+b two layers › RelE-like › RelE-like › RelE-like | 0.68 | 47.0 | 5.36e-01 | 89.2% | 98.7% |
| 4937737 | 4312.1.1.0 ↗ | a+b two layers › RelE-like › RelE-like › RelE-like | 0.67 | 52.0 | 5.62e-01 | 89.2% | 97.6% |
| 5044967 | 4312.1.1.3 ↗ | a+b two layers › RelE-like › RelE-like › RelE-like › ParE_toxin | 0.67 | 54.0 | 5.77e-01 | 94.1% | 97.8% |
| 4966797 | 4312.1.1.0 ↗ | a+b two layers › RelE-like › RelE-like › RelE-like | 0.67 | 53.0 | 5.74e-01 | 94.1% | 100.0% |
| 4937366 | 4312.1.1.3 ↗ | a+b two layers › RelE-like › RelE-like › RelE-like › ParE_toxin | 0.66 | 53.0 | 5.53e-01 | 92.2% | 90.5% |
| 3589339 | 4312.1.1.0 ↗ | a+b two layers › RelE-like › RelE-like › RelE-like | 0.66 | 55.0 | 5.67e-01 | 98.0% | 95.8% |
| 5018712 | 4312.1.1.3 ↗ | a+b two layers › RelE-like › RelE-like › RelE-like › ParE_toxin | 0.66 | 54.0 | 5.70e-01 | 94.1% | 98.9% |
| 4949569 | 4312.1.1.3 ↗ | a+b two layers › RelE-like › RelE-like › RelE-like › ParE_toxin | 0.66 | 52.0 | 5.56e-01 | 97.1% | 96.7% |
| 4463632 | 4312.1.1.3 ↗ | a+b two layers › RelE-like › RelE-like › RelE-like › ParE_toxin | 0.65 | 53.0 | 5.67e-01 | 91.2% | 98.9% |
| 4928898 | 243.3.1.0 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin | 0.64 | 38.0 | 4.37e-01 | 90.2% | 80.0% |
| 2770566 | 4312.1.1.3 ↗ | a+b two layers › RelE-like › RelE-like › RelE-like › ParE_toxin | 0.64 | 55.0 | 5.73e-01 | 92.2% | 98.9% |
| 3965259 | 243.3.1.16 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin › PepSY_2 | 0.64 | 35.0 | 4.13e-01 | 90.2% | 75.7% |
| 4544637 | 4312.1.1.3 ↗ | a+b two layers › RelE-like › RelE-like › RelE-like › ParE_toxin | 0.64 | 53.0 | 5.55e-01 | 92.2% | 96.8% |
| 1678533 | 243.3.1.10 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin › YPEB_PepSY1-2 | 0.62 | 38.0 | 4.46e-01 | 90.2% | 90.0% |
| 5019886 | 243.3.1.3 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin › PepSY | 0.61 | 38.0 | 4.36e-01 | 91.2% | 85.3% |
| 1170463 | 243.3.1.3 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin › PepSY | 0.60 | 37.0 | 3.87e-01 | 92.2% | 67.0% |
| 3722681 | 331.3.1.30 ↗ | a+b two layers › TBP-like › Bet v1-like › Bet v1-like › DUF3074 | 0.60 | 45.0 | 3.28e-01 | 80.4% | 90.2% |
| 3286735 | 243.3.1.3 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin › PepSY | 0.60 | 37.0 | 4.00e-01 | 91.2% | 72.9% |
| 5078519 | 4312.1.1.3 ↗ | a+b two layers › RelE-like › RelE-like › RelE-like › ParE_toxin | 0.60 | 51.0 | 5.32e-01 | 92.2% | 98.9% |
| 5029970 | 4312.1.1.0 ↗ | a+b two layers › RelE-like › RelE-like › RelE-like | 0.59 | 48.0 | 4.95e-01 | 96.1% | 90.9% |
| 5014687 | 243.3.1.0 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin | 0.58 | 35.0 | 4.17e-01 | 91.2% | 93.8% |
| 3691227 | 216.1.1.4 ↗ | a+b two layers › UBC-like › UBC-like › UBC-like › RWD | 0.58 | 36.0 | 3.48e-01 | 91.2% | 55.7% |
| 3702918 | 331.3.1.3 ↗ | a+b two layers › TBP-like › Bet v1-like › Bet v1-like › START | 0.55 | 41.0 | 3.15e-01 | 79.4% | 73.6% |
| 4114694 | 71.1.1.0 ↗ | beta meanders › Lipoprotein localization factors LolAB › Lipoprotein localization factors LolAB › Lipoprotein localization factors LolAB | 0.54 | 45.0 | 4.11e-01 | 91.2% | 97.9% |
| 3176080 | 5.1.4.0 ↗ | beta duplicates or obligate multimers › beta-propeller-like › beta-propeller › 7-bladed | 0.54 | 49.0 | 3.14e-01 | 100.0% | 34.6% |
| 3923382 | 5.1.11.15 ↗ | beta duplicates or obligate multimers › beta-propeller-like › beta-propeller › 9-bladed › DPPIV_N | 0.53 | 49.0 | 3.14e-01 | 100.0% | 34.4% |
| 3584285 | 5.1.11.15 ↗ | beta duplicates or obligate multimers › beta-propeller-like › beta-propeller › 9-bladed › DPPIV_N | 0.53 | 49.0 | 3.17e-01 | 100.0% | 36.7% |
| 4997289 | 3692.1.1.1 ↗ | a+b two layers › Ornithine cyclodeaminase-like enzymes dimerization domain › Ornithine cyclodeaminase-like enzymes dimerization domain › Ornithine cyclodeaminase-like enzymes dimerization domain › OCD_Mu_crystall | 0.52 | 37.0 | 3.57e-01 | 86.3% | 62.6% |
| 3338395 | 222.1.1.1 ↗ | a+b two layers › Thioesterase/thiol ester dehydrase-isomerase-like › Thioesterase/thiol ester dehydrase-isomerase › Thioesterase/thiol ester dehydrase-isomerase › MaoC_dehydratas | 0.52 | 38.0 | 3.46e-01 | 77.5% | 98.6% |
| 4977909 | 331.10.2.0 ↗ | a+b two layers › TBP-like › S-adenosylmethionine decarboxylase-related › Bacterial S-adenosylmethionine decarboxylase | 0.52 | 33.0 | 3.29e-01 | 91.2% | 59.1% |
| 3605927 | 708.1.1.0 ↗ | beta complex topology › ETN0001 domain-like › ETN0001 domain-like › NAC/WRKY/GCM/WOPR domain | 0.52 | 41.0 | 3.94e-01 | 85.3% | 85.0% |
| 3241172 | 243.1.1.2 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › NTF2 | 0.52 | 42.0 | 4.13e-01 | 91.2% | 92.2% |
| 3177736 | 5.1.4.0 ↗ | beta duplicates or obligate multimers › beta-propeller-like › beta-propeller › 7-bladed | 0.52 | 42.0 | 2.72e-01 | 89.2% | 30.7% |
| 3505062 | 226.1.1.1 ↗ | a+b two layers › POZ domain › POZ domain › POZ domain › BTB | 0.51 | 38.0 | 3.38e-01 | 86.3% | 54.5% |
| 4024970 | 5.1.5.0 ↗ | beta duplicates or obligate multimers › beta-propeller-like › beta-propeller › 8-bladed | 0.51 | 45.0 | 3.02e-01 | 100.0% | 41.9% |
| 3559155 | 1020.1.1.63 ↗ | extended segments › Ezh2 N-terminal domain › Ezh2 N-terminal domain › Ezh2 N-terminal domain › CATSPERG_beta-prop | 0.50 | 46.0 | 3.00e-01 | 100.0% | 32.5% |